Stryker Corp
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Inari Medical by Year
Inari Medical — U.S. FDA 510(k) Clearances (Ongoing Post-Acquisition, clearances)
Stryker Inari Medical: 4 in FY2025, unchanged from a year earlier. That is the lowest of the 8 years on record here.
Where the FY2025 figure comes from
Source: U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗
Reported in U.S. FDA openFDA & NIH ClinicalTrials.gov (Inari Medical, through 2026-09).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Inari Medical — U.S. FDA 510(k) Clearances (Ongoing Post-Acquisition, clearances) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | 0.0% | U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗ |
| FY2024 | Dec 31, 2024 | 4 | -75.0% | U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗ |
| FY2023 | Dec 31, 2023 | 16 | +166.7% | U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗ |
| FY2022 | Dec 31, 2022 | 6 | +20.0% | U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗ |
| FY2021 | Dec 31, 2021 | 5 | +25.0% | U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗ |
| FY2020 | Dec 31, 2020 | 4 | 0.0% | U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗ |
| FY2019 | Dec 31, 2019 | 4 | -50.0% | U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗ |
| FY2018 | Dec 31, 2018 | 8 | – | U.S. FDA openFDA Device Clearances & MAUDE — Inari Medical ↗ |
Breakdown
What makes up inari Medical
Cite this data
StockData. (2026). Stryker Inari Medical, annual FY2018–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/nari-fda-510k
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.